Clinical Trials Sponsored by Notal Vision Ltd

Total 93 results

Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT

Age-Related Macular Degeneration | Diabetic Retinopathy
Notal Vision Ltd.

Completed

Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging

AMD Population - Intermediate or Advanced AMD | DR Population- With or Without Diabetic Macular Edema

Israel
Notal Vision Ltd.

Withdrawn

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Age Related Macular Degeneration | Choroidal Neovascularization

France
Notal Vision Ltd.

Completed

Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Foresee Home for Monitoring Age Related Macular Degeneration (AMD) (Foresee Home)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Home Retinal Imaging Using NOTAL-OCT V3.0

A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment

Israel
Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT V2.5

AMD

Israel
Notal Vision Ltd.

Completed

Macular Thickness Measurements Using Retinal-thickness OCT

Age-Related Macular Degeneration | Diabetic Retinopathy

Israel
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment (AMD)

Age-Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Usability of the PreView PHP for Home Use in Intermediate AMD Patients

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV) (PHP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT V3.0

AMD | DR

Israel
Notal Vision Ltd.

Completed

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device (AREDS)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

HMP (Home Macular Perimeter) -Usability Trial

Age Related Macular Degeneration
Notal Vision Ltd.

Completed

Sensitivity of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration | Choroidal Neovascularization

United States
Notal Vision Ltd.

Completed

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration (CNV)

Age Related Macular Degeneration | Choroidal Neovascularization

United States
Notal Vision Ltd.

Completed

Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Usage of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients (UU2)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Usability Study (AMD)

Age Related Macular Degeneration
Notal Vision Ltd.

Completed

Sensitivity and Specificity of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.
Elman Retina Group

Completed

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

Diabetic Macular Edema | AMD - Age-Related Macular Degeneration

United States
Notal Vision Inc.

Recruiting

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

Diabetic Macular Edema

United States
Notal Vision Inc.

Completed

The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT

Neovascular Age-related Macular Degeneration

United States
Notal Vision Inc.

Completed

Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study

Neovascular Age-related Macular Degeneration

United States
Notal Vision Inc.

Recruiting

Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD

Retinal Neovascularization

United States
Notal Vision Inc.

Recruiting

Home OCT Fluid Visualization Agreement Study

Neovascular Age-related Macular Degeneration

United States
Notal Vision Inc.

Completed

Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients

Diabetic Retinopathy

Israel
Notal Vision Inc.

Active, not recruiting

ForeseeHome NRich Registry

Age-Related Macular Degeneration

United States
Notal Vision Inc.

Completed

Single In-Clinic Encounter With the Notal Vision Home OCT

Neovascular Age-related Macular Degeneration | Intermediate Age Related Macular Degeneration (Disorder)

United States
Notal Vision Inc.

Completed

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

Retinal Neovascularization

United States
Visco Vision Inc.
Jens Medical Consulting Ltd.

Completed

the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens

Myopia

Taiwan
Peili Vision Ltd.

Recruiting

Assessment of ARVO Web-based Software for Evaluating Attention-Deficit/Hyperactive Disorder (ADHD) Symptoms in Children

Attention Deficit Disorder With Hyperactivity

Finland
CorNeat Vision Ltd.

Terminated

First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness

Corneal Opacity | Corneal Disease | Corneal Injuries

France, United States, Canada, Netherlands, Israel
CorNeat Vision Ltd.

Active, not recruiting

Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants (EverPatch)

Glaucoma Eye | Tissue Breakdown

Canada, France, Georgia
LUMA Vision Ltd.

Not yet recruiting

Registry on Luma Vision's VERAFEYE System (ENLIgHT) (ENLIgHT)

Atrial Fibrillation | Left Atrial Appendage Closure | Atrial Arrhythmia
CorNeat Vision Ltd.

Recruiting

Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness

Corneal Opacity | Corneal Disease | Corneal Injuries

France, Canada, Israel, Netherlands
CorNeat Vision Ltd.

Terminated

First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute

Glaucoma Eye | Tissue Breakdown

Canada, France, Kenya
LUMA Vision Ltd.

Not yet recruiting

Feasibility Study on the VERAFEYE System (LUMINIzE)

Atrial Fibrillation | Atrial Septal Defect | Left Atrial Appendage Closure | Atrial Arrhythmia
Visior Technologies Ltd.

Unknown

Modulation of Brain Blood Flow Using Dichoptic Visual and Auditory Stimulation

Cerebral Arterial Diseases

Israel
Visior Technologies Ltd.

Completed

Assessment of Device for Treatment of Amblyopia

Amblyopia

Israel
Medic Vision Imaging Solutions Ltd

Recruiting

Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.

MRI Image Enhancement

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-angle Glaucoma

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride (SEATTLE)

Geographic Atrophy

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

Dry Eye Syndrome

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Geographic Atrophy | Dry Age-related Macular Degeneration

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

Dry Eye | Keratoconjunctivitis Sicca

United States

Clinical Trials Sponsored by Notal Vision Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations